pI: 6.7641 |
Length (AA): 192 |
MW (Da): 22030 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
47 | 191 | 2xri (A) | 131 | 269 | 45.00 | 0 | 1 | 1.33061 | -0.85 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127645)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G45330 | 2' tRNA phosphotransferase |
Arabidopsis thaliana | AT5G23600 | tRNA 2'phosphotransferase |
Brugia malayi | Bm1_05475 | exonuclease family protein |
Candida albicans | CaO19.5432 | likely tRNA 2'-phosphotransferase similar to S. cerevisiae TPT1 (YOL102C) responsible for the last step of tRNA splicing |
Candida albicans | CaO19.12887 | likely tRNA 2'-phosphotransferase similar to S. cerevisiae TPT1 (YOL102C) responsible for the last step of tRNA splicing |
Caenorhabditis elegans | CELE_M02B7.2 | Protein M02B7.2 |
Caenorhabditis elegans | CELE_R02D3.8 | Protein R02D3.8 |
Cryptosporidium hominis | Chro.20133 | CG33057-PA |
Cryptosporidium parvum | cgd2_1210 | conserved hypothetical protein |
Dictyostelium discoideum | DDB_G0286929 | hypothetical protein |
Drosophila melanogaster | Dmel_CG33057 | CG33057 gene product from transcript CG33057-RB |
Escherichia coli | b4331 | RNA 2'-phosphotransferase |
Echinococcus granulosus | EgrG_000057100 | Exonuclease RNase T DNA polymerase III |
Echinococcus multilocularis | EmuJ_000057100 | Exonuclease, RNase T DNA polymerase III |
Homo sapiens | ENSG00000117419 | ERI1 exoribonuclease family member 3 |
Homo sapiens | ENSG00000149743 | tRNA phosphotransferase 1 |
Leishmania braziliensis | LbrM.24.0830 | phosphotransferase, putative |
Leishmania donovani | LdBPK_240830.1 | phosphotransferase, putative |
Leishmania infantum | LinJ.24.0830 | phosphotransferase, putative |
Leishmania major | LmjF.24.0810 | phosphotransferase, putative |
Leishmania mexicana | LmxM.24.0810 | phosphotransferase, putative |
Loa Loa (eye worm) | LOAG_10927 | exonuclease |
Mus musculus | ENSMUSG00000047656 | tRNA phosphotransferase 1 |
Mus musculus | ENSMUSG00000033423 | exoribonuclease 3 |
Neospora caninum | NCLIV_032600 | tRNA splicing 2 phosphotransferase 1, putative |
Neospora caninum | NCLIV_029770 | TRNA splicing 2 phosphotransferase 1, related |
Oryza sativa | 4326611 | Os01g0618000 |
Oryza sativa | 4350620 | Os11g0525900 |
Onchocerca volvulus | OVOC3906 | ERI1 exoribonuclease 3 homolog |
Saccharomyces cerevisiae | YOL102C | Tpt1p |
Schistosoma mansoni | Smp_157760 | prion interactor pint1 |
Schistosoma mansoni | Smp_142480 | tRNA splicing 2' phosphotransferase 1 |
Schmidtea mediterranea | mk4.007803.00 | |
Trypanosoma brucei gambiense | Tbg972.11.6190 | phosphotransferase, putative |
Trypanosoma brucei | Tb927.11.5480 | phosphotransferase, putative |
Trypanosoma congolense | TcIL3000.11.5760 | phosphotransferase, putative |
Trypanosoma cruzi | TcCLB.508647.250 | phosphotransferase, putative |
Toxoplasma gondii | TGME49_257290 | RNA 2'-phosphotransferase, Tpt1/KptA family protein |
Toxoplasma gondii | TGME49_232640 | RNA 2'-phosphotransferase, Tpt1/KptA family protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.02.3160 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.3160 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.3160 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb11.02.3160 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b4331 | Escherichia coli | non-essential | goodall |
YOL102C | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_257290 | Toxoplasma gondii | Probably essential | sidik |
TGME49_232640 | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Candida albicans | likely tRNA 2'-phosphotransferase similar to S. cerevisiae TPT1 (YOL102C) responsible for the last step of tRNA splicing | Compounds | References |